Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.839
+0.004 (0.47%)
At close: Mar 9, 2026, 4:00 PM EDT
0.850
+0.011 (1.31%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Citius Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Market Capitalization | 19 | 21 | 90 | 109 | 177 | 296 | |
| Market Cap Growth | 18.07% | -76.68% | -16.79% | -38.51% | -40.33% | 413.63% | |
| Enterprise Value | 13 | 19 | 73 | 77 | 130 | 182 | |
| Last Close Price | 0.84 | 1.24 | 12.52 | 17.11 | 30.25 | 50.75 | |
| PB Ratio | 0.23 | 0.27 | 1.22 | 1.19 | 1.71 | 2.23 | |
| P/TBV Ratio | - | - | - | 4.92 | 5.19 | 4.67 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -0.06 | -0.03 | -0.04 | -0.28 | -0.40 | -0.52 | |
| Net Debt / EBITDA Ratio | 0.16 | 0.06 | 0.07 | 0.71 | 1.23 | 2.94 | |
| Net Debt / FCF Ratio | 0.17 | 0.09 | 0.11 | 0.90 | 1.45 | 2.85 | |
| Quick Ratio | 0.31 | 0.10 | 0.09 | 4.58 | 9.21 | 17.60 | |
| Current Ratio | 0.99 | 0.62 | 0.40 | 5.95 | 9.84 | 18.29 | |
| Return on Equity (ROE) | -47.85% | -52.42% | -47.63% | -33.40% | -28.48% | -27.70% | |
| Return on Assets (ROA) | -17.68% | -19.45% | -23.83% | -21.10% | -16.24% | -15.80% | |
| Return on Capital Employed (ROCE) | -36.10% | -44.80% | -52.00% | -37.50% | -30.40% | -17.00% | |
| Earnings Yield | -191.15% | -177.45% | -43.26% | -29.93% | -19.03% | -7.78% | |
| FCF Yield | -185.55% | -125.87% | -31.17% | -26.73% | -16.04% | -8.19% | |
| Buyback Yield / Dilution | -107.77% | -64.49% | -11.16% | -3.57% | -34.52% | -177.28% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.